Ordu, C. Et Al. 2016. Prognostic relevance of sunitinib toxicities and comparison of continuous vs. intermittent sunitinib dosing schedule in metastatic renal cell cancer patients. WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY , vol.20, no.2 , 147-152.

Ordu, C., Pilanci, K. N., Avci, N., YILDIZ, İ., Alco, G., Demirhan, O., ... Koksal, U. I.(2016). Prognostic relevance of sunitinib toxicities and comparison of continuous vs. intermittent sunitinib dosing schedule in metastatic renal cell cancer patients. WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY , vol.20, no.2, 147-152.

Ordu, Cetin Et Al. "Prognostic relevance of sunitinib toxicities and comparison of continuous vs. intermittent sunitinib dosing schedule in metastatic renal cell cancer patients," WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY , vol.20, no.2, 147-152, 2016

Ordu, Cetin Et Al. "Prognostic relevance of sunitinib toxicities and comparison of continuous vs. intermittent sunitinib dosing schedule in metastatic renal cell cancer patients." WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY , vol.20, no.2, pp.147-152, 2016

Ordu, C. Et Al. (2016) . "Prognostic relevance of sunitinib toxicities and comparison of continuous vs. intermittent sunitinib dosing schedule in metastatic renal cell cancer patients." WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY , vol.20, no.2, pp.147-152.

@article{article, author={Cetin Ordu Et Al. }, title={Prognostic relevance of sunitinib toxicities and comparison of continuous vs. intermittent sunitinib dosing schedule in metastatic renal cell cancer patients}, journal={WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY}, year=2016, pages={147-152} }